pharma news, views and analysis

in News

NHS App could offer video consultations by 2024

June 29, 2022

NHS App could offer video consultations by 2024

https://pharmaphorum.com/news/nhs-app-could-offer-video-consultations-by-2024/

The NHS App will be updated over the next couple of years to include a series of new

in News

NHS England reveals travel plan to cut waiting lists

June 27, 2022

NHS England reveals travel plan to cut waiting lists

https://pharmaphorum.com/news/nhs-england-reveals-travel-plan-to-cut-waiting-lists/

NHS patients in England who have been waiting more than two years for surgery will be offered treatment

Latest News

Biogen and Happify partner on digital support for MS patients

Digital health company Happify has signed a partnership with another biopharma company, joining forces with Biogen on a

Biogen and Happify partner on digital support for MS patients

https://pharmaphorum.com/news/biogen-and-happify-partner-on-digital-support-for-ms-patients/

GSK pledges £1bn drive for infectious disease R&D

GSK will invest around £1 billion ($1.2 billion) over a 10-year period to speed up R&D on infectious

GSK pledges £1bn drive for infectious disease R&D

https://pharmaphorum.com/news/gsk-pledges-1bn-drive-for-infectious-disease-rd/

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

Moderna says COVID booster works against Omicron subvariants

Moderna has reported top-line data suggesting that its COVID-19 booster vaccine candidate stimulates a strong immune response against

Moderna says COVID booster works against Omicron subvariants

https://pharmaphorum.com/news/moderna-says-covid-booster-works-against-omicron-subvariants/

See all

Views & analysis

Questions linger as England’s Innovative Medicines Fund kicks off

In part one of this two-article series on the latest on England’s Innovative Medicines Fund (IMF), Leela Barham

Questions linger as England’s Innovative Medicines Fund kicks off

https://pharmaphorum.com/market-access-2/questions-linger-as-englands-innovative-medicines-fund-kicks-off/

England’s Innovative Medicines Fund hits another milestone

Leela Barham takes a look at the latest milestone on what will have been a close to three-year

England’s Innovative Medicines Fund hits another milestone

https://pharmaphorum.com/market-access-2/englands-innovative-medicines-fund-hits-another-milestone/

Appreciating pharmacists’ role in healthcare

Parisa “Risa” Vatanka, PharmD, CTTS, senior director of corporate alliances at the American Pharmacists Association (APhA), tells us

Appreciating pharmacists’ role in healthcare

https://pharmaphorum.com/patients/appreciating-pharmacists-role-in-healthcare/

See all

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Can simulated datasets unlock the potential of patient data?

Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

See all

Partner Content

Understanding the True Impact of the COVID-19 Pandemic on the Immunocompromised

Complexities demonstrate the need for more resources

Understanding the True Impact of the COVID-19 Pandemic on the Immunocompromised

https://pharmaphorum.com/partner-content/understanding-the-true-impact-of-the-covid-19-pandemic-on-the-immunocompromised/

How to Provide Value that Benefits Patients (and Your Brand)

Identify opportunities by condition or therapeutic area

How to Provide Value that Benefits Patients (and Your Brand)

https://pharmaphorum.com/partner-content/how-to-provide-value-that-benefits-patients-and-your-brand/

3 Reasons for Pharma Marketers to Leverage Social Health

Meet patients in the moments that matter

3 Reasons for Pharma Marketers to Leverage Social Health

https://pharmaphorum.com/partner-content/3-reasons-for-pharma-marketers-to-leverage-social-health/

See all

Trending

Login